Alzheimer’s Association International Convention (AAIC) 2023
Jul 16 - Jul 20, 2023
Developing Topics Poster Session: Basic Science and Pathogenesis
July 16, 2023
Poster P1-1008: Brain transcriptomic and proteomic analyses in an in vivo AD model further elucidate the role of the sigma-2 receptor modulator CT1812 in Alzheimer’s disease
To view poster, click here
Alzheimer’s Association Business Consortium
July 18, 2023 at 1 p.m. EST / 6 a.m. CDT
Panel Discussion – Developing and Commercializing Precision Medicine: Partnerships and Emerging Biomarkers & Treatments
Moderator:
Ornit Chiba-Falek, PhD: CLAIRIgene Co-Founder
Panelists:
ary Hamby, PhD: Cognition Therapeutics Vice President of Research
Codi Gharagouzloo, MSc, PhD: Imaginostics Scientific Founder & CEO
CJ Barnum, PhD: InmuneBio Head of Neuroscience
Sudhir Sivakumaran, PhD: Critical Path for Alzheimer's Disease (CPAD) Executive Director